Skip to main content
. 2013 Jul 30;30(6):671–678. doi: 10.1093/fampra/cmt038

Table 2.

Comparison of demographic characteristics and clinical diagnoses

High-dose group (n = 60) Traditional dose group (n = 60) P value
Age 57.3 (9.8) 57.2 (13.01) 0.986
Male 95.0% (57) 88.3% (53) 0.186
Race
 Caucasian 70.0% (42) 60.0% (36) 0.251
 Not reported 25.0% (15) 38.3% (23) 0.116
 Other 5.0% (3) 1.7% (1) 0.309
Marital status
 Married 51.7% (31) 58.3% (35) 0.463
 Separated or divorced 33.3% (20) 31.7% (19) 0.845
 Single 11.7% (7) 5.0% (3) 0.186
 Widowed 3.3% (2) 5.0% (3) 0.648
VA service connected 98.3% (59) 98.3% (59) 1.00
Average daily dose in morphine equivalent 398.7mg (722.2) 23.9mg (15.5) <0.001
 Median daily opioid dose 268.3 mg 20.3 mg
Pain intensity 6.6 (1.7) 6.5 (1.2) 0.527
Pain diagnoses
 Neck or joint pain 73.3% (44) 76.7% (46) 0.673
 Low back pain 76.7% (46) 63.3% (38) 0.111
 Arthritis 70.0% (42) 56.7% (34) 0.130
 Neuropathy 16.7% (10) 21.7% (13) 0.487
 Migraine 11.7% (7) 15.0% (9) 0.591
 Fibromyalgia 11.7% (7) 8.3% (5) 0.543
Psychiatric diagnoses
 Depression 61.7% (37) 58.3% (35) 0.709
 Dysthymia 18.3% (11) 15.0% (9) 0.624
 Bipolar disorder 0.0% (0) 8.3% (5) 0.022
 PTSD 41.7% (25) 31.7% (19) 0.256
 Panic disorder 10.0% (6) 8.3% (5) 0.752
 Other anxiety disorders 20.0% (12) 20.0% (12) 1.000
 Schizophrenia 0.0% (0) 5.0% (3) 0.079
 Substance use disorder 30.0% (18) 25.0% (15) 0.540
Tobacco use 38.3% (23) 35.0% (21) 0.705

PTSD, post-traumatic stress disorder. Column values indicate % (n) for categorical variables or mean ± SD for continuous variables.